NephroGenex, Inc.·4

Nov 12, 11:54 AM ET

NephroGenex, Inc. 4

4 · NephroGenex, Inc. · Filed Nov 12, 2015

Insider Transaction Report

Form 4
Period: 2015-11-10
Hamill John
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2015-11-10+136,381136,381 total
Footnotes (1)
  • [F1]All shares of common stock are represented by unvested restricted stock units. The restricted stock units will vest in equal quarterly installments over a three year period beginning January 1, 2016.

Documents

1 file
  • 4
    wf-form4_144734724205337.xmlPrimary

    FORM 4